SEDIABETES - www.sediabetes.org/revista
Back issues
See article
Av. Diabetol. 2010;26(2):112-118

Smaller font size Bigger font size Print text

Longitudinal study of the impact of the treatment with insulin infusion in psychological, quality of life, and glycemic control of patient with type 1 diabetes mellitus

Original Articles - Vol.26 N.2  Marc-april 2010
M.T.Anarte1, M.S. Ruiz de Adana2, M. Carreira, M. Domínguez-López3, A. Machado4, I. González Molero5, F.F. Caballero6, M. de la Higuera7, S. González Romero8, I.Sánchez9, F.J. C.-Soriguer Escofet10

 Author Affiliations


Abstract

Introduction: Since the DCCT study, many studies have tried to assess dif- ferent intensive therapies. However, few long-term studies have included psy- chosocial variables. Objectives: To evaluate psychological and metabolic var- iables in patients with type 1 diabetes after 2 years of therapy with continuous subcutaneous insulin infusion (CSII). Materials and methods: Twenty-two type 1 diabetic patients treated with multiple daily injections were treated with CSII. An evaluation at 6, 12 and 24 months was performed, using several in- struments as BDI, DQOL, MHLC and a questionnaire to evaluate fear of hy- poglycaemia. Acceptable metabolic control was admitted with HbA1c <7.5%. Statistical analysis was realized using non parametric tests and Pearson’s cor- relation coefficient. Results: Initially, patients had a mean score for depression of 9.55 ± 9.12 (mean ± SD). In quality of life, initial values were 92.95 ± 16.15, while the level of HbA1c was 8.45 ± 1.59%. After 2 years of treatment we found significant improvement in depression (p= 0.018) and quality of life (p= 0.005) scores and glycemic control (p= 0.003). Trait anxiety and external locus of control showed a significant correlation, with a strong correlation be- tween fear of hypoglycemia and the analyzed psychosocial variables. Patients with bad basal glycemic control improved after 2 years of treatment. Conclu sions: After two years with CSII, type 1 diabetic patients improve significantly their quality of life, glycemic control and depressive symptoms.

Correspondence

Correspondencia: M.T. Anarte Ortiz. Departamento de Personalidad, Evaluación y Tratamiento Psicológico.
Facultad de Psicología. Universidad de Málaga. Campus de Teatinos. 29071 Málaga.
Correo electrónico: anarte@uma.es

Keywords

anxiety quality of life continuous subcutaneous insulin infusion depression type 1 diabetes mellitus type 2 diabetes mellitus Continuous Subcutaneous Insulin Infusion insulin pump locus of control.

Document

PDF Document

‹ Back